These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 3028819)
1. Evidence for an association between CD23 and the receptor for a low molecular weight B cell growth factor. Gordon J; Webb AJ; Walker L; Guy GR; Rowe M Eur J Immunol; 1986 Dec; 16(12):1627-30. PubMed ID: 3028819 [TBL] [Abstract][Full Text] [Related]
2. B cell growth and differentiation factors interact with receptors distinct from the interleukin 2 receptor. Kehrl JH; Grove JH; Goldsmith PK; Fauci AS Eur J Immunol; 1986 Jul; 16(7):761-6. PubMed ID: 3013645 [TBL] [Abstract][Full Text] [Related]
3. Synergy of B cell growth factor and interleukin 2 in the proliferation of activated human B cells. Romagnani S; Giudizi GM; Maggi E; Almerigogna F; Biagiotti R; Del Prete G; Mazzetti M; Alessi A; Vercelli D; Ricci M Eur J Immunol; 1985 Dec; 15(12):1158-64. PubMed ID: 3936718 [TBL] [Abstract][Full Text] [Related]
5. Ligation of the CD23,p45 (BLAST-2,EBVCS) antigen triggers the cell-cycle progression of activated B lymphocytes. Gordon J; Rowe M; Walker L; Guy G Eur J Immunol; 1986 Sep; 16(9):1075-80. PubMed ID: 2428624 [TBL] [Abstract][Full Text] [Related]
6. Characterization of the cell surface receptors for human B cell growth factor of 12,000 molecular weight. Mehta SR; Grant SR; Maizel AL J Immunol; 1986 Oct; 137(7):2210-4. PubMed ID: 3093567 [TBL] [Abstract][Full Text] [Related]
7. Triggering of B lymphocytes through CD23: epitope mapping and studies using antibody derivatives indicate an allosteric mechanism of signalling. Gordon J; Webb AJ; Guy GR; Walker L Immunology; 1987 Apr; 60(4):517-21. PubMed ID: 2438206 [TBL] [Abstract][Full Text] [Related]
8. Low molecular weight B cell growth factor-responsive cloned human B cell lines. I. Phenotypic differences and lack of requirement for CD23 (Fc epsilon RII). Warrington RJ; Rutherford WJ; Wong SK; Cook JM; Rector ES J Immunol; 1989 Oct; 143(8):2546-52. PubMed ID: 2529311 [TBL] [Abstract][Full Text] [Related]
9. A monoclonal anti-mouse LFA-1 alpha antibody mimics the biological effects of B cell stimulatory factor-1 (BSF-1). Mishra GC; Berton MT; Oliver KG; Krammer PH; Uhr JW; Vitetta ES J Immunol; 1986 Sep; 137(5):1590-8. PubMed ID: 3091687 [TBL] [Abstract][Full Text] [Related]
10. Human B cell responsiveness to B cell growth factor after activation by phorbol ester and monoclonal anti-mu antibody. Suzuki T; Butler JL; Cooper MD J Immunol; 1985 Apr; 134(4):2470-6. PubMed ID: 2982946 [TBL] [Abstract][Full Text] [Related]
11. Coordinated action of IgE and a B-cell-stimulatory factor on the CD23 receptor molecule up-regulates B-lymphocyte growth. Guy GR; Gordon J Proc Natl Acad Sci U S A; 1987 Sep; 84(17):6239-43. PubMed ID: 2957693 [TBL] [Abstract][Full Text] [Related]
12. Development and characterization of a human B cell line that responds to B cell growth factor but not interleukin 2. Tseng CT; Springgate CF; Piela TH; Choi YS J Immunol; 1987 Apr; 138(8):2554-60. PubMed ID: 3031160 [TBL] [Abstract][Full Text] [Related]
13. B cell growth-promoting activity of recombinant human interleukin 4. Defrance T; Vanbervliet B; Aubry JP; Takebe Y; Arai N; Miyajima A; Yokota T; Lee F; Arai K; de Vries JE J Immunol; 1987 Aug; 139(4):1135-41. PubMed ID: 3112225 [TBL] [Abstract][Full Text] [Related]
14. Sequential effect of a high molecular weight B cell growth factor and of interleukin 2 on activated human B cells. Vazquez A; Auffredou MT; Gerard JP; Delfraissy JF; Galanaud P J Immunol; 1987 Oct; 139(7):2344-8. PubMed ID: 3116080 [TBL] [Abstract][Full Text] [Related]
15. Reactivity of Leu-1+ tonsillar B cells to a high molecular weight B cell growth factor. Richard Y; Leprince C; Dugas B; Treton D; Galanaud P J Immunol; 1987 Sep; 139(5):1563-7. PubMed ID: 3114370 [TBL] [Abstract][Full Text] [Related]
16. Identification of a receptor for high molecular weight human B cell growth factor. Ambrus JL; Jurgensen CH; Brown EJ; McFarland P; Fauci AS J Immunol; 1988 Aug; 141(3):861-9. PubMed ID: 3260914 [TBL] [Abstract][Full Text] [Related]
17. Augmentation of normal and malignant B cell proliferation by monoclonal antibody to the B cell-specific antigen BP50 (CDW40). Ledbetter JA; Shu G; Gallagher M; Clark EA J Immunol; 1987 Feb; 138(3):788-94. PubMed ID: 3492534 [TBL] [Abstract][Full Text] [Related]
18. Functional studies examining the subpopulation of human B lymphocytes responding to high molecular weight B cell growth factor. Ambrus JL; Chesky L; Stephany D; McFarland P; Mostowski H; Fauci AS J Immunol; 1990 Dec; 145(12):3949-55. PubMed ID: 2258603 [TBL] [Abstract][Full Text] [Related]
19. Analysis of the role of interferon-gamma, interleukin 2 and a third factor distinct from interferon-gamma and interleukin 2 in human B cell proliferation. Evidence that they act at different times after B cell activation. Romagnani S; Giudizi GM; Almerigogna F; Biagiotti R; Alessi A; Mingari C; Liang CM; Moretta L; Ricci M Eur J Immunol; 1986 Jun; 16(6):623-9. PubMed ID: 3087756 [TBL] [Abstract][Full Text] [Related]
20. Differential effects of interleukin 2 vs B cell growth factor on human B cells. Nakagawa T; Nakagawa N; Ambrus JL; Fauci AS J Immunol; 1988 Jan; 140(2):465-9. PubMed ID: 2447179 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]